Coeptis Therapeutics Holdings, Inc., a leading biopharmaceutical company, has announced the successful acquisition of the NexGenAI Affiliates Network platform. This milestone is accompanied by the official launch of Coeptis Technologies, a new division focused on diversifying the company's growth strategy. The acquisition highlights Coeptis' commitment to leveraging cutting-edge technologies to optimize marketing strategies, streamline operations, and deliver innovative solutions in highly regulated industries like biotech, pharmaceuticals, and multi-level marketing (MLM).

Key Highlights of the Acquisition

1. NexGenAI Affiliates Network Platform

Developed by NexGenAI Solutions Group, Inc., this groundbreaking platform integrates:

• AI-Powered Marketing Software: Empowers marketers to process large datasets, enhance customer engagement, and optimize campaigns.
• Robotic Process Automation (RPA): Automates repetitive tasks, boosting operational efficiency.

The platform is strategically designed to tackle challenges in highly competitive and regulated industries by offering tools that drive measurable results.

2. Launch of Coeptis Technologies

This new division aims to diversify Coeptis' growth trajectory by focusing on innovation in cell therapy platforms and advanced marketing technologies.

Statements from Key Leaders

Dave Mehalick, President and CEO of Coeptis Therapeutics:

"We are excited to integrate the NexGenAI Affiliates Network platform and its AI and RPA-driven tools into our offerings. In industries like biotech, pharma, and MLM, where competition is high and regulatory challenges are complex, having advanced tools to optimize marketing and streamline operations is critical. This acquisition marks a significant step forward for Coeptis in providing transformative solutions that align with our innovative vision."

Anshuman Dash, Lead Advisor of NexGenAI:

"The integration of NexGenAI's innovative AI-powered marketing solutions with Coeptis Therapeutics' forward-thinking approach represents a transformative leap. This collaboration enhances Coeptis' ability to revolutionize marketing strategies and operational efficiencies in regulated sectors, delivering greater value to its partners."

Impact on the Biopharmaceutical Sector

With this acquisition, Coeptis aims to:

• Enhance Capabilities: Leverage AI-powered tools to overcome marketing challenges in competitive industries.
• Streamline Operations: Improve efficiency through advanced RPA-driven solutions.
• Drive Innovation: Align technological advancements with the company’s mission of delivering impactful solutions in healthcare and other sectors.

The acquisition of NexGenAI Affiliates Network platform and the launch of Coeptis Technologies reflect Coeptis Therapeutics’ dedication to innovation and growth. By integrating state-of-the-art AI and RPA tools, the company is poised to transform marketing and operational strategies in highly regulated industries, cementing its position as a leader in the biopharmaceutical landscape.